terms |
nimotuzumab |
As nouns the difference between terms and nimotuzumab
is that
terms is while
nimotuzumab is a monoclonal antibody used to treat squamous cell carcinoma, head and neck cancer, nasopharyngeal cancer, and glioma.
glioma |
nimotuzumab |
As nouns the difference between glioma and nimotuzumab
is that
glioma is glioma (a brain tumor) while
nimotuzumab is a monoclonal antibody used to treat squamous cell carcinoma, head and neck cancer, nasopharyngeal cancer, and glioma.
nasopharyngeal |
nimotuzumab |
As an adjective nasopharyngeal
is of or pertaining to the nose and the pharynx.
As a noun nimotuzumab is
a monoclonal antibody used to treat squamous cell carcinoma, head and neck cancer, nasopharyngeal cancer, and glioma.
cancer |
nimotuzumab |
As nouns the difference between cancer and nimotuzumab
is that
cancer is cancer while
nimotuzumab is a monoclonal antibody used to treat squamous cell carcinoma, head and neck cancer, nasopharyngeal cancer, and glioma.